FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
CVBF collaborated with IRCSS Istituto Clinico Humanitas and Bruschettini Srl on an article published on the Frontiers in Neurology Journal, entitled “Cox [...]
CVBF Head of Bio-Statistics lecturer at the Università Campus Bio-Medico di Roma
On 29 April 2023, Giorgio Reggiardo, our experienced research methodologist and biostatistician, held a presentation to the students of the second [...]
Clinical Research on Medical Devices. How to maximize the benefit for the patients? – CVBF will tackle the topic of Regulatory Aspects on Medical Devices
Donato Bonifazi, our CEO, will attend as a speaker, the conference "La ricerca clinica profit e no profit su farmaci e device: [...]
Poland and Italy amid the crises and challenges in the healthcare sector – Practice and Experience
The Conference “Poland and Italy amid the crises and challenges in the healthcare sector – Practice and Experience” organized by [...]
Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19 – A Meta-analysis
Emerging data points to the increase of the global prevalence of child and adolescent mental illnesses during COVID-19. To precisely [...]
Gianni Benzi Foundation Special Issue “Personalized Medicine in Blood Disease of Children”: submit your paper
Do you deal with child blood non-malignant diseases? Are you interested in personalised medicine and biomarkers or genomics as well [...]
Duchenne Data Foundation 3rd International Muscle-Bone Interaction in Duchenne Muscular Dystrophy Symposium
The latest international standards of care for Duchenne muscular dystrophy (DMD) were published in 2018, leading to a greater emphasis [...]
EMA Guidance for medicine developers and companies on COVID-19
The European Medicines Agency (EMA) released a guidance for medicine developers and pharmaceutical companies to help speed up medicine and vaccine development and approval for [...]
EPTRI AT THE ECDR 2020 MEETING
On May 14-16th over 1,500 people from 57 different countries, representing all stakeholder groups in the rare disease community, joined together at the 10th European [...]
International Clinical Trials Day 2020
International Clinical Trials Day is held on 20 May each year since 2005 to commemorate the day that James Lind began his famous trial for [...]
EUROPE: COVID-19 – Overview of European Regulatory Authority Guidance by country
Covid-19 pandemic is representing an unprecedented challenge for the governments and their healthcare and economical systems, who are working hardly to develop the proper legislative [...]
Newsletter, MARCH 2020
30th March 2020 Newsletter March 2020 News New Publication: The Lancet Haematology Journal The results of DEEP-2 study have been accepted for publication on The [...]
SAVE THE DATE. EPTRI Virtual Meeting, 2-3 April 2020
Due to the progress of the situation related to the new coronavirus infection and the declaration of the pandemic status by the WHO, the management [...]







